About Us
Governance
Transparency and Excellence at the Heart of Healthcare Innovation
As a strategic hub for the acceleration and commercialization of innovation in healthcare technologies, MEDTEQ+’s governance ensures that our principles of transparency, integrity and collaboration are maintained, keeping a watchful eye on the organization’s support, financing and networking activities. It also contributes to ensuring the quality development of leading-edge healthcare solutions, in compliance with the highest standards of excellence.
Our Board of Directors, made up of experts from the industry, academia and clinical practice, guides our strategies and initiatives. With their experience and vision, we make informed decisions that address today’s health and wellness challenges.
Board of Directors
François Bastien
Telus Santé
Chairman of the Board
André Diamant
Gray Oncology
Industrial Vice-President, Small Business and Secretary
René Boyer
Siemens Healthineers
Industrial Vice-President Large Companies
François Bertrand
Polytechnique Montréal
Academic Vice-President
Martin Beaumont
CHU de Québec–Université Laval
Treasurer
Geneviève Lavertu
Johnson & Johnson
Industrial Member
Marc-Sébastien Verrault
Medtronic
Industrial Member
Michel Blain
Exo-S
Industrial Member, Chairman, Governance Committee
Pierre Bérubé
Solutions Greybox
Industrial Member
Jonathan Vallée
Laboratoires Daya
Industrial Member
Martin Ducharme
AlayaCare
Industrial Member, Chairman of SIREC
Dominique Bérubé
McGill University
Academic Member
Kaouther Bessrour
Laval University
Academic Member
Yves Joanette
Université de Montréal
Academic Member
Marie-Ève Desrosiers
Centre hospitalier de l’Université de Montréal
Health Network Member
Alexandre Le Bouthillier
Independent Member
Brenda Irwin
Independent Member
Emmanuel Daigneault
Independent Member
Daria Riabinina
Ministère de l’Économie, de l’Innovation et de l’Énergie
Observer
Stéphanie Doyle
Montréal InVivo
Observer
Vanessa Marsan
Ministère de l’Économie, de l’Innovation et de l’Énergie
Observer
Executive Committee
François Bastien
Telus Santé
Chairman of the Executive Committee
André Diamant
Gray Oncology
Industrial Vice-President, Small Business and Secretary
René Boyer
Siemens Healthineers
Industrial Vice-President Large Companies
François Bertrand
Polytechnique Montréal
Academic Vice-President
Martin Beaumont
CHU de Québec–Université Laval
Treasurer
Governance Committee
Michel Blain
Exo-S
Chairman, Governance Committee
François Bastien
Telus Santé
Geneviève Lavertu
Johnson & Johnson
Kaouther Bessrour
Université Laval
Scientific and Industrial Relevance Evaluation Committee (SIREC)
Our Scientific and Industrial Relevance Evaluation Committee is made up of independent experts from industry, academia, clinicians and patient representatives. Its mandate is to evaluate each project from various angles: potential economic benefits, commercial potential, scientific rigour and clinical need. Its main role is to support companies, researchers and institutions in the creation and implementation of innovative healthcare technologies, to select projects with high impact potential, to improve proposals and to ensure the match between needs and technology.
Strategic Partnerships
MEDTEQ+ collaborates with various experts in the healthcare field, including universities, companies and government agencies. These partnerships strengthen our ability to innovate and implement projects that meet the market needs.
Commitment to Corporate Social Responsibility
We also care about our social and environmental impact. MEDTEQ+ integrates corporate social responsibility (CSR) practices into its governance, contributing to the sustainable development of our community.